Nur Hidayah Kaz Abdul Aziz

Nur Hidayah Kaz Abdul Aziz


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2025 in Molecules
Verified
Journal Article
Open access
PDF file
YDYousaf Dawood
Yousaf Dawood
Atheer ZgairAtheer Zgair
Atheer Zgair
MYMun Fei Yam
Mun Fei Yam
NANur Hidayah Kaz Abdul Aziz
Nur Hidayah Kaz Abdul Aziz
Background/Objectives: Aldose reductase (AR) plays a crucial role in the accumulation of oxidative factors that lead to oxidative stress-related neuroinflammation. This study aims to find a novel agent from natural sources that can inhibit AR. Methods: Different extracts of Orthosiphon stamineus Benth (OS) leaves and its active constituents, eupatorin (EUP), rosmarinic acid (RA), sinensetin (SEN) and 3-hydroxy-5,6,7,4-tetramethoxyflavone (TMF), were used to identify the potential inhibition effect of AR. A new high-performance liquid chromatography (HPLC) method was developed to determine these phytochemicals using the Shimadzu LC-20AD HPLC system. In addition, the in vitro inhibition effect of OS ethanol extracts (95% and 50%) and OS components EUP, RA, and SEN was investigated in recombinant AR (AKR1B1). Results: In this study, the developed HPLC method was precise and accurate, and demonstrated clear separation of the four compounds—EUP, RA, SEN, and TMF—in the ethanolic extract. The contents of the four selected compounds—EUP, RA, SEN, and TMF—in 95% ethanolic extract were 2.35, 11.91, 0.94, and 0.18%, respectively. RA showed the highest concentration among the selected compounds, indicating that RA is the major constituent of this plant. The in vitro assay showed significant inhibition of the AR enzyme by RA and OS ethanol extracts 95% and 50% (IC50: 41.42 µM; 63.42 µg/mL and 93.22 µg/mL, respectively). Conclusions: The ethanolic extract of OS and RA could be a promising therapeutics option for the treatment of oxidative stress-related neuroinflammation disorders by inhibiting AR.

28 July 2022 in International Journal of Pharmaceutical Investigation
Verified
Journal Article
Open access
PDF file
MBMuhammad Irfan Bashir
Muhammad Irfan Bashir
NANur Hidayah Kaz Abdul Aziz
Nur Hidayah Kaz Abdul Aziz
DNDzul Azri Mohamed Noor
Dzul Azri Mohamed Noor
Background: Monoamine oxidase-A (MAO-A) enzyme is responsible for the breakdown of monoamines (serotonin and norepinephrine). MAO-A is also a target to treat the depressive disorders. Kruppel-likefactor11(KLF11) and Sirtuin1(SIRT1) are the main transcriptional activators of MAO-A. Polygonum minus (P. minus) aqueous extract showed some neuroprotective properties in previous studies like improved memory and positive mood. The aim of current study was to evaluate the effects of P. minus aqueous effects on KLF11 and SIRT1 levels in hippocampus of stressed mice. Materials and Methods: Balb/c mice (22g-26g) were used in this study and P. minus aqueous extract was administered for 8 weeks with three different doses (P. minus 50mg, P. minus 100 mg and P. minus 200mg) in different groups. Amitriptyline 20 mg was used as positive control antidepressant. Chronic ultra-mild stress protocol was used for 6 weeks to induce the depression among mice groups except control group. Results: The results showed that all doses of P. minus reduce the KLF11 level significantly but only P. minus 200mg showed reduction in SIRT1 level in hippocampus of mice significantly. Conclusion: It is concluded that P. minus aqueous extract treatment showed a significant reverse in an elevated level of KLF11 and SIRT1 in hippocampus of stressed mice after treatment of 8 weeks

19 August 2026 in Molecules
Verified
Journal Article
Open access
PDF file
YDYousaf Dawood
Yousaf Dawood
Atheer ZgairAtheer Zgair
Atheer Zgair
MYMun Fei Yam
Mun Fei Yam
NANur Hidayah Kaz Abdul Aziz
Nur Hidayah Kaz Abdul Aziz
Background: Traditional antidepressants are associated with undesirable side effects, limited efficacy, and delayed therapeutic responses. Natural products have emerged as a potential alternative to these drugs. This research aimed to investigate the antidepressant-like activity and possible mechanism of Orthosiphon stamineus (OS) leaf ethanolic extract. Methods: Molecular docking and in vitro studies were performed to assess the inhibitory activity of ethanolic extracts of OS leaves against the monoamine oxidase (MAO-A) enzyme. Behavioral tests were used to evaluate the antidepressant-like activity of the 95% ethanol extract in reserpine-treated rats, followed by histopathological examination and measurement of hippocampal serotonin (5-HT), norepinephrine (NE), and brain-derived neurotrophic factor (BDNF). Results: The main active compounds, particularly rosmarinic acid and eupatorin, exhibited favorable binding affinities to the MAO-A active site. The 95% and 50% ethanol extracts of OS showed dose-dependent MAO-A inhibitory activity with ICs50 of 88.67 and 103.2 µg/mL, respectively. The 95% ethanol extract of OS leaves showed a significant reduction in immobility time, restored locomotor activity, and preserved hippocampal morphology. Notably, the higher dose of OS extract (150 mg/kg) significantly enhanced hippocampal expression of 5-HT and NE, with a moderate upregulation of BDNF. Conclusions: These findings suggest that the 95% ethanol extract of OS leaves exhibits promising antidepressant-like effects, which may be mediated through monoamine modulation and BDNF expression and partially through MAO-A enzyme inhibition.

31 December 2022 in Malaysian Journal of Pharmacy
Verified
Journal Article
Closed access
SCSiok Yee Chan
Siok Yee Chan
RAReem Abou Assi
Reem Abou Assi
IAIbrahim M Abdulbaqi
Ibrahim M Abdulbaqi
MZMohammed Zawiah
Mohammed Zawiah
NANur Hidayah Kaz Abdul Aziz
Nur Hidayah Kaz Abdul Aziz
Amer Hayat KhanAmer Hayat Khan
Amer Hayat Khan

1 January 2018 in Frontiers in Pharmacology
Verified
Journal Article
Open access
NONabilah Othman
Nabilah Othman
NANur Hidayah Kaz Abdul Aziz
Nur Hidayah Kaz Abdul Aziz
Orthosiphon stamineus (OS) has been traditionally used for many ailments but for psychiatric disorders. Rosmarinic acid (RA) is one of the phenolic compounds contained in OS, and it has been shown to have positive antidepressant-like effect on rats in other studies. The objective of this study is to investigate the effects of standardized ethanolic OS extract on the behaviors of rat dams exposed to gestational stress, which is linked to be a factor of postpartum depressive-like behaviors in rodents. Female Sprague Dawley rats were mated and divided into two groups - stressed and non-stressed. The stressed groups were subjected to chronic mild stress procedure after mating until the day of parturition, whereas non-stressed groups were left undisturbed. After parturition, the stressed group were further divided into 4 groups – non-treated, amitriptyline-treated 20mg/kg, OS-treated 100mg/kg (OS100) and OS-treated 200mg/kg (OS200). Treatments were given via oral once daily until the end of the behavioral tests. After weaning of pups, all rat dams were tested for locomotor activity and anxiety-like behavior in open field test, whereas depression-like behavior was assessed in forced swim test (all groups n: 7-10). In open field test, one-way ANOVA analysis showed that treatments with amitriptyline and both OS concentrations significantly increased the locomotor activity of gestationally-stressed postpartum rats, similar to non-gestationally stressed postpartum rats (p<0.05). No significant anxiety-like behavior was observed in any groups. In forced swim test however, only treatments with amitriptyline and OS100 decreased the immobility behavior similar to the control group (p<0.0001). Standard ethanolic OS extract showed ability to reverse the adverse effect of gestational stress on rats depending on the dose given, hence does have the potential as a treatment for depression at postpartum period.

30 September 2024 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
MBMuhammad Irfan Bashir
Muhammad Irfan Bashir
NANur Hidayah Kaz Abdul Aziz
Nur Hidayah Kaz Abdul Aziz
DNDzul Azri Mohamed Noor
Dzul Azri Mohamed Noor
UIUmar Idris Ibrahim
Umar Idris Ibrahim
ZZZalina Zahari
Zalina Zahari
The aim of the current research was to dock the two abundant bioactive constituents of Polygonum minus leaf extract, in1cluding Quercetin 3-Glucuronide (Miquelianin) and Quercitrin (Quercetin-3-rhamnoside). In-silico Molecular modelling technique was used to predict about a protein (enzyme) interacts with molecules (ligands). Monoamine oxidase-A (MAO-A) is the key enzyme that is involved in the breakdown of neurotransmitters like serotonin and noradrenaline. Drugs that are involved in its inhibition, are considered to be antidepressant agents. This molecular docking study observed the binding energy of selected ligands and their interactions with amino acid residue along with bond types in the MAO-A structure. Molecular docking was done using Molecular Operating Environment (MOE) software, whereas visualization and expression of results were carried out using Discovery Studio (DS) visualizer. Clorgyline was used in this study as a co-crystal ligand, whereas moclobemide was used as a standard MAO-A inhibitor, and Amitriptyline was used as a common antidepressant which also has some MAO-A inhibitory effect. Quercetin 3-glucuronide (Miquelianin) and Quercitrin (Quercetin-3-rhamnoside) have more binding affinities with MAO-A structure as compared to all other drugs. Its interaction pattern was most likely moclobemide and Clorgyline, which are considered standard MAO-A inhibitors in this study. Based on these results, it is concluded that Quercetin 3-Glucuronide (Miquelianin) and Quercitrin (Quercetin-3-rhamnoside) have the potential to become potent MAO-A inhibitors in future.